Update on Anti-Vascular Endothelial Growth Factor Inhibitors in the Treatment of Age-related Macular Degeneration

This webcast is jointly sponsored by A. Webb Roberts Center for CME of Baylor Health Care System and MedNet.

This activity is supported in part by an independent education grant from Genentech and Alcon Research, Ltd.

Specialty: Ophthalmology

Release date: December 2, 2013

Valid through: December 2, 2014

Target Audience:

This webcast is designed to meet the educational needs of ophthalmologists, retina specialists, physician assistants, nurse practitioners, pharmacists, registered nurses, and eye care specialists involved in the treatment and management of patients with age-related macular degeneration (AMD).

Program Overview:

This webcast is intended to improve care of patients with AMD by accelerating adoption of new guidelines and evidence-based practice change. In-depth discussion of novel agents at various stages of clinical development will be given significant focus. This Internet CME activity is designed to provide clinical decision-making strategies for integration of novel therapeutic options.

This program consists of 2 continuing education activites.

Module 1 — Justis P. Ehlers, MD — 0.5 AMA PRA Category 1™ Credit Hours

Module 2 — Peter K. Kaiser, MD — 0.5 AMA PRA Category 1™ Credit Hours